tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
SBFM
Sunshine Biopharma
RESEARCH TOOLSreports

Sunshine Biopharma (SBFM) Financial Statements

426 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently $4.90M. The company's EPS TTM is $-0.19; its P/E ratio is -0.60; Sunshine Biopharma is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Mar 23Dec 21
Income Statement
Total Revenue$ 36.31M$ 34.87M$ 24.09M$ 4.35M$ 228.43K
Gross Profit$ 11.92M$ 10.67M$ 8.34M$ 1.70M$ 110.60K
Operating Income$ -4.48M$ -5.81M$ -4.79M$ -8.67M$ -2.44M
EBITDA$ -4.15M$ -5.14M$ -3.82M$ -26.45M$ -12.09M
Net Income$ -5.98M$ -5.13M$ -4.51M$ -26.74M$ -12.44M
Balance Sheet
Cash & Short-Term Investments$ 9.12M$ 9.69M$ 16.29M$ 21.83M$ 2.05M
Total Assets$ 30.08M$ 30.56M$ 27.35M$ 29.55M$ 2.20M
Total Debt$ 812.42K$ 952.48K$ 657.71K$ 765.26K$ 1.90M
Net Debt$ -8.31M$ -8.73M$ -15.63M$ -21.06M$ -145.17K
Total Liabilities$ 7.04M$ 7.06M$ 6.14M$ 7.92M$ 1.99M
Stockholders' Equity$ 23.04M$ 23.50M$ 21.21M$ 21.63M$ 211.66K
Cash Flow
Free Cash Flow$ -5.51M$ -14.85M$ -9.56M$ -5.55M$ -1.83M
Operating Cash Flow$ -5.33M$ -12.53M$ -8.78M$ -5.25M$ -1.83M
Investing Cash Flow$ -836.31K$ -2.32M$ -656.15K$ -14.62M$ 0.00
Financing Cash Flow$ 4.75M$ 9.29M$ 3.43M$ 39.47M$ 2.90M
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Income Statement >

Sunshine Biopharma Debt to Assets

Balance Sheet >

Sunshine Biopharma Cash Flow

Cash Flow >

Sunshine Biopharma Forecast EPS vs Actual EPS

Earnings >